Super	B-ENHANCER
enhancers	I-ENHANCER
at	I-ENHANCER
the	I-ENHANCER
miR	I-ENHANCER
-	I-ENHANCER
146a	I-ENHANCER
and	I-ENHANCER
miR	I-ENHANCER
-	I-ENHANCER
155	I-ENHANCER
genes	E-ENHANCER
contribute	O
to	O
self	O
-	O
regulation	O
of	O
inflammation	O
.	O


Inflammatory	O
response	O
is	O
essential	O
to	O
host	O
defense	O
and	O
repair	O
,	O
and	O
requires	O
tight	O
regulation	O
as	O
excessive	O
and	O
constant	O
inflammatory	O
response	O
is	O
deleterious	O
.	O


We	O
recently	O
identified	O
that	O
one	O
of	O
the	O
general	O
but	O
key	O
mechanisms	O
for	O
inflammatory	O
gene	O
transcription	O
regulation	O
is	O
controlled	O
by	O
the	O
formation	O
of	O
super	O
enhancers	O
mediated	O
by	O
NF	O
-	O
kappaB	O
,	O
and	O
bromodomain	O
and	O
extraterminal	O
(	O
BET	O
)	O
proteins	O
.	O


Given	O
that	O
microRNA	O
transcription	O
shares	O
a	O
similar	O
mechanism	O
to	O
mRNA	O
,	O
we	O
assume	O
that	O
the	O
inflammatory	O
microRNAs	O
transcription	O
could	O
be	O
NF	O
-	O
kappaB	O
and	O
BET	O
bromodomain	O
dependent	O
.	O


In	O
the	O
present	O
study	O
,	O
we	O
confirmed	O
that	O
inflammatory	O
stimuli	O
changed	O
human	O
umbilical	O
vein	O
endothelial	O
cells	O
(	O
HUVEC	O
)	O
microRNA	O
profile	O
.	O


Among	O
these	O
microRNAs	O
,	O
miR	O
-	O
146a	O
and	O
miR	O
-	O
155	O
,	O
two	O
well	O
-	O
established	O
inflammatory	O
microRNAs	O
,	O
are	O
both	O
downregulated	O
at	O
transcriptional	O
level	O
by	O
NF	O
-	O
kappaB	O
and	O
BET	O
bromodomain	O
inhibition	O
.	O


To	O
pursue	O
this	O
mechanism	O
,	O
we	O
analyzed	O
the	O
ChIP	O
-	O
seq	O
data	O
and	O
found	O
that	O
NF	O
-	O
kappaB	O
,	O
BRD4	O
and	O
RNA	O
POL	O
II	O
were	O
rapidly	O
distributed	O
at	O
the	O
upstream	O
regions	O
of	O
miR	O
-	O
146a	O
and	O
miR	O
-	O
155	O
,	O
and	O
more	O
importantly	O
mediated	O
the	O
formation	O
of	O
the	O
super	B-ENHANCER
enhancers	I-ENHANCER
that	I-ENHANCER
drive	I-ENHANCER
miR	I-ENHANCER
-	I-ENHANCER
146a	I-ENHANCER
and	I-ENHANCER
miR	I-ENHANCER
-	I-ENHANCER
155	I-ENHANCER
transcription	E-ENHANCER
.	O


These	O
microRNAs	O
transcription	O
driven	O
by	O
super	O
enhancers	O
in	O
turn	O
downregulate	O
both	O
in	O
vitro	O
and	O
in	O
vivo	O
canonical	O
inflammatory	O
genes	O
expression	O
through	O
targeting	O
inflammatory	O
mediators	O
.	O


This	O
novel	O
finding	O
demonstrated	O
how	O
the	O
host	O
self	O
-	O
regulates	O
inflammatory	O
genes	O
expression	O
at	O
both	O
transcriptional	O
and	O
post	O
-	O
transcriptional	O
level	O
to	O
ensure	O
the	O
appropriate	O
level	O
of	O
the	O
host	O
inflammatory	O
response	O
.	O
